Sign in to view content

Efficacy and Safety Outcomes Over 12 Weeks With OCS-01 Eye Drops in DME From DIAMOND-Stage 1 Trial:Focus on Subgroup by Prior Treatment Status

Baruch D. Kuppermann, MD, PhD

Video
Published 2025

Related

Relationship between Change in Visual Acuity and Change in Retinal Thickness during Treatment of Diabetic Macular Edema with Anti-VEGF
Daniel F. Rosberger, MD, PhD, MPH
On Demand Cases, Courses, and Papers
2019
Imaging Signatures and Cytokine Expression in Diabetic Macular Edema From the IMAGINE Study: Biomarker Exploration for Precision Medicine
Sruthi Arepalli, MD
On Demand Cases, Courses, and Papers
2020
Foveal Capillary Perfusion Density Decreases in Diabetics with DME Treated on a Fixed Regimen of Intravitreal Aflibercept Injections Over 24 Months
Brittney Statler, MD
Updates from the Field
2020

Category: Retinal Vascular Disease

See more